Form 8-K · Current report
News Corp 8-K, filed Sep 25, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000209
Summary
News Corp repurchased 62,323 of its Class A common shares on September 24, 2026 for about US$1.77 million as part of its 2025 Repurchase Program, which authorizes up to US$1 billion in aggregate buybacks of its Class A and Class B common stock. Cumulative purchases under the program stand at roughly US$496.3 million in consideration paid.
Key points
- News Corp bought back 62,323 Class A common shares on September 24, 2026, paying approximately US$1,769,624.19.
- Prices paid on that day ranged from US$28.21 to US$28.74 per share.
- The 2025 Repurchase Program, authorized as of July 15, 2025, covers up to US$1 billion in aggregate of Nasdaq-listed Class A and Class B common stock, with no ASX-listed CDIs to be repurchased.
- To date News Corp has purchased about US$496,302,268 worth of Class A and Class B shares under the program.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.